A detailed history of Two Sigma Investments, LP transactions in Celcuity Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 44,221 shares of CELC stock, worth $715,937. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,221
Holding current value
$715,937
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $607,596 - $955,173
44,221 New
44,221 $955,000
Q1 2022

May 16, 2022

SELL
$7.93 - $13.33 $124,508 - $209,294
-15,701 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$11.96 - $19.35 $46,297 - $74,903
-3,871 Reduced 19.78%
15,701 $207,000
Q3 2021

Nov 15, 2021

BUY
$17.35 - $24.87 $339,574 - $486,755
19,572 New
19,572 $352,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $242M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.